Stephan Probst

7.2k total citations · 2 hit papers
109 papers, 2.4k citations indexed

About

Stephan Probst is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Stephan Probst has authored 109 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Pulmonary and Respiratory Medicine, 34 papers in Radiology, Nuclear Medicine and Imaging and 25 papers in Oncology. Recurrent topics in Stephan Probst's work include Prostate Cancer Treatment and Research (34 papers), Radiopharmaceutical Chemistry and Applications (26 papers) and Gastric Cancer Management and Outcomes (23 papers). Stephan Probst is often cited by papers focused on Prostate Cancer Treatment and Research (34 papers), Radiopharmaceutical Chemistry and Applications (26 papers) and Gastric Cancer Management and Outcomes (23 papers). Stephan Probst collaborates with scholars based in Canada, United States and Germany. Stephan Probst's co-authors include Nils Homann, Claudia Pauligk, Ralf‐Dieter Hofheinz, Elke Jäger, Salah‐Eddin Al‐Batran, Volker Rethwisch, Jan Stoehlmacher, J. T. Hartmann, G. Seipelt and Harald Schmalenberg and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and The Journal of Urology.

In The Last Decade

Stephan Probst

104 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phase III Trial in Metastatic Gastroesophageal Adenocarcinoma with Fluorouracil, Leucovorin Plus Either Oxaliplatin or Cisplatin: A Study of the Arbeitsgemeinschaft Internistische Onkologie

2008 568 citations Salah‐Eddin Al‐Batran, Stephan Probst et al. profile →
A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with ¹⁸ F-DCFPyL in Prostate Cancer Patients (OSPREY)

2021 244 citations Stephan Probst et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stephan Probst Canada	20	1.6k	734	660	454	411	109	2.4k
Woong Sub Koom South Korea	29	1.1k 0.7×	1.4k 1.9×	1.7k 2.5×	506 1.1×	68 0.2×	165	3.2k
Mitsuru Matsuki Japan	26	480 0.3×	529 0.7×	304 0.5×	995 2.2×	71 0.2×	102	1.9k
Takuo Hayashi Japan	30	1.4k 0.8×	725 1.0×	967 1.5×	184 0.4×	121 0.3×	211	2.9k
Giovanni Corso Italy	34	1.1k 0.7×	1.5k 2.0×	737 1.1×	150 0.3×	286 0.7×	171	3.4k
Philip A. Linden United States	24	1.4k 0.9×	636 0.9×	671 1.0×	625 1.4×	56 0.1×	112	2.7k
Peter Oppelt United States	31	479 0.3×	430 0.6×	800 1.2×	58 0.1×	62 0.2×	149	2.8k
Darrell D. Davidson United States	29	736 0.5×	842 1.1×	792 1.2×	158 0.3×	52 0.1×	82	2.5k
Mitsuharu Miwa Japan	17	635 0.4×	727 1.0×	427 0.6×	325 0.7×	88 0.2×	39	1.8k
Gerald J. Heatley United States	26	419 0.3×	1.1k 1.5×	548 0.8×	103 0.2×	90 0.2×	41	2.6k
Erin R. Rudzinski United States	29	1.7k 1.1×	421 0.6×	814 1.2×	45 0.1×	82 0.2×	99	2.9k

Countries citing papers authored by Stephan Probst

Since Specialization

Citations

This map shows the geographic impact of Stephan Probst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephan Probst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephan Probst more than expected).

Fields of papers citing papers by Stephan Probst

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephan Probst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephan Probst. The network helps show where Stephan Probst may publish in the future.

Co-authorship network of co-authors of Stephan Probst

This figure shows the co-authorship network connecting the top 25 collaborators of Stephan Probst. A scholar is included among the top collaborators of Stephan Probst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephan Probst. Stephan Probst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Azoulay, Laurent, et al.. (2024). Variants of physiological FDG vascular activity on digital PET. Nuclear Medicine Communications. 46(3). 239–244. 1 indexed citations

Chaddad, Ahmad, Michael Jonathan Kucharczyk, Abbas Cheddad, et al.. (2021). Magnetic Resonance Imaging Based Radiomic Models of Prostate Cancer: A Narrative Review. Cancers. 13(3). 552–552. 26 indexed citations

Mancini, Rita, Stephan Probst, Gad Abikhzer, et al.. (2021). Sarcopenia in cardiac surgery: Dual X-ray absorptiometry study from the McGill frailty registry. American Heart Journal. 239. 52–58. 12 indexed citations

Probst, Stephan, et al.. (2020). Weight loss as primary indication for FDG-PET/CT. Nuclear Medicine Communications. 41(10). 1066–1072. 1 indexed citations

Abikhzer, Gad, et al.. (2020). Physiologic prostate-specific membrane antigen-targeted 18F-DCFPyL uptake in the epididymis head newly appreciated on digital PET/CT. Nuclear Medicine Communications. 42(5). 490–494. 2 indexed citations

Anidjar, Maurice, et al.. (2018). 18F-fluorocholine positron emission tomography-computed tomography (18F-FCH PET/CT) for staging of high-risk prostate cancer patients. Canadian Urological Association Journal. 13(4). 84–91. 6 indexed citations

How, Jeffrey, Susie Lau, Shannon Salvador, et al.. (2017). Unexpected locations of sentinel lymph nodes in endometrial cancer. Gynecologic Oncology. 147(1). 18–23. 31 indexed citations

Al‐Batran, Salah‐Eddin, Claudia Pauligk, Nils Homann, et al.. (2017). Docetaxel, oxaliplatin, and fluorouracil/leucovorin (FLOT) versus epirubicin, cisplatin, and fluorouracil or capecitabine (ECF/ECX) as perioperative treatment of resectable gastric or gastro-esophageal junction adenocarcinoma: The multicenter, randomized phase 3 FLOT4 trial (German Gastric Group at AIO). Annals of Oncology. 28. iii152–iii153. 18 indexed citations

Niazi, Tamim, et al.. (2017). Biopsy-Proven Diffuse Mediastinal Prostate Cancer Metastases Negative on 18F-Fluorocholine, Diagnosed on 68Ga-PSMA and 18F-PSMA PET/CT. Clinical Nuclear Medicine. 42(10). 801–802. 1 indexed citations

10.

Makis, William, Anthony Ciarallo, Tina Petrogiannis‐Haliotis, Arthur Rosenberg, & Stephan Probst. (2017). Follicular lymphoma transforming into diffuse large B-cell lymphoma in spleen: Simultaneous appearance of both on 18 F-FDG PET/CT and histology. Clinical Imaging. 43. 88–92. 2 indexed citations

11.

Makis, William & Stephan Probst. (2016). Extensive polyostotic fibrous dysplasia evaluated for malignant transformation with^99mTc-MDP bone scan and¹⁸F-FDG PET/CT. BJR|case reports. 2(3). 20150440–20150440. 1 indexed citations

12.

How, Jeffrey, Walter H. Gotlieb, Joshua Z. Press, et al.. (2015). Comparing indocyanine green, technetium, and blue dye for sentinel lymph node mapping in endometrial cancer. Gynecologic Oncology. 137(3). 436–442. 124 indexed citations

13.

Probst, Stephan, et al.. (2013). Atypical Bisphosphonate-Associated Subtrochanteric and Femoral Shaft Stress Fractures. Clinical Nuclear Medicine. 38(5). 397–399. 16 indexed citations

14.

Makis, William, Anthony Ciarallo, Rajan Rakheja, et al.. (2012). Spectrum of malignant renal and urinary bladder tumors on 18F-FDG PET/CT: a pictorial essay. Clinical Imaging. 36(6). 660–673. 6 indexed citations

15.

Probst, Stephan, et al.. (2011). The Appearance of Epidural Extranodal Marginal Zone Lymphoma (MALToma) on F-18 FDG PET/CT and Post Hoc PET/MRI Fusion. Clinical Nuclear Medicine. 36(4). 303–304. 3 indexed citations

16.

Probst, Stephan, et al.. (2010). Tc-99m Sestamibi SPECT/CT With Volumetric Reconstruction for Radioguided Occult Lesion Localization and Surgical Excision of Melanoma Metastasis. Clinical Nuclear Medicine. 35(3). 165–167. 1 indexed citations

17.

Eggert‐Kruse, W., G. Rohr, Stephan Probst, et al.. (2009). Antisperm antibodies and microorganisms in genital secretions-a clinically significant relationship?. Andrologia. 30(S1). 61–71. 5 indexed citations

18.

Alabed, Yazan Z., et al.. (2009). Intrathoracic Gastric Activity of Tc-99m Sestamibi in a Patient With Gastric Pull-Up for Esophageal Cancer. Clinical Nuclear Medicine. 34(9). 632–633. 1 indexed citations

19.

Eggert‐Kruse, W., G. Rohr, Stephan Probst, et al.. (1996). Immunology: Antibodies to Chlamydia trachomatis in semen and relationship with parameters of male fertility. Human Reproduction. 11(7). 1408–1417. 56 indexed citations

20.

Eggert‐Kruse, W., Stephan Probst, G. Rohr, Wolfgang Tilgen, & B. Runnebaum. (1996). Induction of immunoresponse by subclinical male genital tract infection?. Fertility and Sterility. 65(6). 1202–1209. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact